Detalles de la búsqueda
1.
Effects of a topical treatment with spleen tyrosine kinase inhibitor in healthy subjects and patients with cold urticaria or chronic spontaneous urticaria: Results of a phase 1a/b randomised double-blind placebo-controlled study.
Br J Clin Pharmacol
; 87(12): 4797-4808, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34020509
2.
A model of skin inflammation in humans leads to a rapid and reproducible increase in the interferon response signature: a potential translational model for drug development.
Inflamm Res
; 64(3-4): 171-83, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25596950
3.
Ultrasonographic measures of synovitis in an early phase clinical trial: a double-blind, randomised, placebo and comparator controlled phase IIa trial of GW274150 (a selective inducible nitric oxide synthase inhibitor) in rheumatoid arthritis.
Clin Exp Rheumatol
; 30(2): 254-61, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22409880
4.
The ASCEND study: protocol for a feasibility study to evaluate an early social communication intervention for young children with Down syndrome.
Pilot Feasibility Stud
; 8(1): 8, 2022 Jan 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-35039084
5.
Correlation of skin blanching and percutaneous absorption for glucocorticoid receptor agonists by matrix-assisted laser desorption ionization mass spectrometry imaging and liquid extraction surface analysis with nanoelectrospray ionization mass spectrometry.
Anal Chem
; 82(18): 7787-94, 2010 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20715787
6.
Safety of Repeated Open-Label Treatment Courses of Intravenous Ofatumumab, a Human Anti-CD20 Monoclonal Antibody, in Rheumatoid Arthritis: Results from Three Clinical Trials.
PLoS One
; 11(6): e0157961, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27336685
Resultados
1 -
6
de 6
1
Próxima >
>>